Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("CNS drugs")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 16 of 16

  • Page / 1
Export

Selection :

  • and

Preparation and characterization of liposomal formulations of neurotensin-degrading enzyme inhibitorsVAN ROOY, Inge; WU, Shin-Ying; STORM, Gert et al.International journal of pharmaceutics (Print). 2011, Vol 416, Num 2, pp 448-452, issn 0378-5173, 5 p.Conference Paper

Recent advances in the prediction of blood-brain partitioning from molecular structureLOBELL, Mario; MOLNAR, Laszlo; KESERÜ, György M et al.Journal of pharmaceutical sciences. 2003, Vol 92, Num 2, pp 360-370, issn 0022-3549, 11 p.Article

Activation of PKC isoform β1 at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brainRIGOR, Robert R; HAWKINS, Brian T; MILLER, David S et al.Journal of cerebral blood flow and metabolism. 2010, Vol 30, Num 7, pp 1373-1383, issn 0271-678X, 11 p.Article

Intranasal Drug Delivery to the Central Nervous System: Present Status and Future OutlookKHOSROW TAYEBATI, Seyed; EJIKE NWANKWO, Innocent; AMENTA, Francesco et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 3, pp 510-526, issn 1381-6128, 17 p.Article

A review of late-stage CNS drug candidates for the treatment of obesityHEAL, D. J; GOSDEN, J; SMITH, S. L et al.International journal of obesity. 2013, Vol 37, Num 1, pp 107-117, issn 0307-0565, 11 p.Article

Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics. CommentaryMORTENSEN, J. T; OLSEN, J; LARSEN, H et al.European journal of epidemiology. 2003, Vol 18, Num 8, pp 743-744, issn 0393-2990, 5 p.Article

In Vivo Methods to Study Uptake of Nanoparticles into the BrainVAN ROOY, Inge; CAKIR-TASCIOGLU, Serpil; HENNINK, Wim E et al.Pharmaceutical research. 2011, Vol 28, Num 3, pp 456-471, issn 0724-8741, 16 p.Article

Analysis of topiramate and its metabolites in plasma and urine of healthy subjects and patients with epilepsy by use of a novel liquid chromatography-mass spectrometry assayBRITZI, Malka; SOBACK, Stefan; ISOHERRANEN, Nina et al.Therapeutic drug monitoring. 2003, Vol 25, Num 3, pp 314-322, issn 0163-4356, 9 p.Article

PERIPHERAL IMMUNOMODULATION WITH GINSENOSIDE RG1 AMELIORATES NEUROINFLAMMATION-INDUCED BEHAVIORAL DEFICITS IN RATSZHENG, X; LIANG, Y; HAO, H.-P et al.Neuroscience. 2014, Vol 256, pp 210-222, issn 0306-4522, 13 p.Article

How well do Lipophilicity Parameters, MEEKC Microemulsion Capacity Factor, and Plasma Protein Binding Predict CNS Tissue Binding?ZAMEK-GLISZCZYNSKI, Maciej J; SPRAGUE, Karen E; ESPADA, Alfonso et al.Journal of pharmaceutical sciences. 2012, Vol 101, Num 5, pp 1932-1940, issn 0022-3549, 9 p.Article

Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat ModelCHARLTON, Stuart T; WHETSTONE, Joanne; FAYINKA, Susan T et al.Pharmaceutical research. 2008, Vol 25, Num 7, pp 1531-1543, issn 0724-8741, 13 p.Article

Solid lipid nanoparticles for targeted brain drug deliveryBLASI, Paolo; GIOVAGNOLI, Stefano; SCHOUBBEN, Aurelie et al.Advanced drug delivery reviews. 2007, Vol 59, Num 6, pp 454-477, issn 0169-409X, 24 p.Article

Medulloblastoma in childhood: revisiting intrathecal therapy in infants and childrenCONROY, Sharon; GARNETT, Martin; VLOEBERGHS, Michael et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 6, pp 1173-1189, issn 0344-5704, 17 p.Article

Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D1 and antagonist at D2 receptors, in ratsYAN SUN; JIEYU DAI; ZHEYI HU et al.British journal of pharmacology. 2009, Vol 158, Num 5, pp 1302-1312, issn 0007-1188, 11 p.Article

Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticlesKREUTER, Jörg; RAMGE, Peter; PETROV, Valery et al.Pharmaceutical research. 2003, Vol 20, Num 3, pp 409-416, issn 0724-8741, 8 p.Article

6-Aryl-3-pyrrolidinylpyridines as mGlu5 receptor negative allosteric modulatorsWEISS, Jesse M; JIMENEZ, Hermogenes N; GUIYING LI et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 16, pp 4891-4899, issn 0960-894X, 9 p.Article

  • Page / 1